FindTrial
Sign In

Effect of oral Pregabalin over regional block for upper limb surgeries in terms of onset and duration of action.

Effect of oral Pregabalin on Supraclavicular Brachial Plexus Block for upper limb surgery: a prospective randomized controlled double blinded study. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070678
Enrollment
72
Registered
2024-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: group P: In group P the patients will receive pregabalin capsule of 150 mg orally two hours before surgery with a sip of water.Supraclavicular brachial plexus block will be performed un

Sponsors

DR RASHMI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients of physical status I or II of ASA, aged between 18 to 65 years, posted for upper limb surgery below the level of mid humerus

Exclusion criteria

Exclusion criteria: patients with preexisting peripheral neuropathy of upper limb, bleeding disorders, infection at the site of injection, untreated pneumothorax, patient refusal, patient switched to GA or inadequate block requiring additional sedation, 0bese and sick patients, patients receiving chronic analgesic or steroid therapy.

Design outcomes

Primary

MeasureTime frame
Effect of tablet Pregabalin on Supraclavicular Brachial plexus Block in terms of duration of blockade. Timepoint: Duration of blockade- 24 hours—

Secondary

MeasureTime frame
Assess the Sedation ScoreTimepoint: 24 Hours—

Countries

India

Contacts

Public ContactRashmi

Rajarajeswari medical college and hospital

rashmi.rp16@gmail.com9986665368

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026